West Pharmaceutical Services

By person

31 insiders · 132 transactions

54.3×

Eric M. Green holds 54.3 times base salary in stock. $64.02M of shares against $1.18M in salary for 2025.

Salary from the company's own proxy. The shares are what Eric M. Green last reported holding, valued at $365.00, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Green Eric Mark

President, CEO and Board Chair

—

$114.69M (30) scheduled

−$114.69M

175,409

0.2492%

$64.02M

+252.6%

FEDERICI WILLIAM J

Sr. VP & CFO

—

$15.98M (5) scheduled

−$15.98M

227,812

0.3237%

$83.15M

+8.5%

Lai Quintin J

VP Strat & Investor Relations

—

$15.77M (14) scheduled

−$15.77M

7,295

0.0104%

$2.66M

—

Favorite Annette F

Sr. VP & Chief HR Officer

—

$14.69M (16) scheduled

−$14.69M

26,621

0.0378%

$9.72M

+120.0%

Birkett Bernard

Sr VP, Chief Financial Officer

—

$13.11M (6) scheduled

−$13.11M

7,520

0.0107%

$2.74M

+1,256%

Abraham Silji

SVP, Chief Technology Officer

—

$12.89M (12) scheduled

−$12.89M

3,138

0.0045%

$1.15M

+170.9%

MONTECALVO DAVID A

SVP, Glob Ops and Supply Chain

—

$4.73M (6) scheduled

−$4.73M

13,731

0.0195%

$5.01M

+567,314%

MILLER GEORGE LLOYD

Sr. VP, GC & Corp. Sec.

—

$3.01M (3) scheduled

−$3.01M

25,467

0.0362%

$9.30M

+169.5%

Witherspoon Charles

VP & Treasurer

—

$2.64M (9) scheduled

−$2.64M

1,408

0.0020%

$513.88K

−1.3%

Flynn Karen

Sr VP & Chief Commercial Offic

—

$2.38M (1) scheduled

−$2.38M

24,990

0.0355%

$9.12M

+67.6%

Malone Daniel

Vice President & Controller

—

$1.42M (3) scheduled

−$1.42M

35,756

0.0508%

$13.05M

+15.3%

Reiss-Clark Cindy

Chief Commercial Officer

—

$1.37M (1) scheduled

−$1.37M

5,047

0.0072%

$1.84M

+50.1%

Winters Chad

VP, Chief Accounting Officer

—

$915.38K (3) scheduled

−$915.38K

1,523

0.0022%

$555.83K

+206.9%

Hofmann Thomas W

Director

—

$668.85K (2)

−$668.85K

44,637

0.0634%

$16.29M

+20.8%

Johnson Paula A

Director

—

$187.10K (1)

−$187.10K

48,754

0.0693%

$17.80M

+2.8%

ZENNER PATRICK J

Director

$95.96K (5)

$47.35K (5)

+$48.61K

55,682

0.0791%

$20.32M

−5.7%

Michels Douglas A

Director

—

46,496

0.0661%

$16.97M

+28.5%

WEILAND JOHN H

Director

—

45,359

0.0645%

$16.56M

+8.4%

BUTHMAN MARK A

Director

—

44,309

0.0630%

$16.17M

+30.3%

Feehery William F

Director

—

32,519

0.0462%

$11.87M

+46.4%

LAI GOLDMAN MYLA

Director

—

20,435

0.0290%

$7.46M

+101.9%

Pucci Paolo

Director

—

11,854

0.0168%

$4.33M

+668.6%

Keller Deborah L

Director

—

11,560

0.0164%

$4.22M

+690.5%

McMahon Robert W.

SVP & Chief Financial Officer

—

7,021

0.0100%

$2.56M

—

FRIEL ROBERT F

Director

—

5,513

0.0078%

$2.01M

+12,730%

Joseph Molly

Director

—

4,398

0.0062%

$1.61M

+956.8%

Lockhart Stephen H

Director

—

3,523

0.0050%

$1.29M

+12,824%

HAUGEN JANET BRUTSCHEA

Director

—

2,373

0.0034%

$866.05K

+2,635%

MacKay Kimberly Banks

SVP, GC & Corporate Secretary

—

1,512

0.0021%

$551.86K

+103,174%

Campbell Shane Alden

SVP, Proprietary Segment

—

613

0.0009%

$223.67K

+881.0%

Poussot Rodolphe Jean

SVP, Strategy & Corporate Dev

—

561

0.0008%

$204.85K

+121.9%

West Pharmaceutical Services

By person

Individual transactions

What was left out